Parkinsons Archives - Market Exclusive

Home Tags Parkinsons

Here’s What Just Happened With Acorda Therapeutics, Inc. (NASDAQ:ACOR)

ME Contributor - November 21, 2017

Here’s What Just Happened With NeuroDerm Ltd. (NASDAQ:NDRM)

ME Contributor - July 25, 2017

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Is Up On PDUFA: What’s Next?

ME Contributor - January 9, 2017

Voyager Therapeutics Inc (NASDAQ:VYGR) Has Plenty Of Near Term Catalysts To...

ME Contributor - December 8, 2016

Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (NASDAQ:ADMS) And Acorda...

ME Contributor - August 5, 2016

Cynapsus Therapeutics Inc (NASDAQ:CYNA) Is Closing In On A Parkinson’s NDA

ME Contributor - July 19, 2016

Taking A Look At Adamas Pharmaceuticals Inc (NASDAQ:ADMS)’s Upcoming Parkinson’s NDA

Roger Hannington - June 23, 2016

EDITOR PICKS

Market Morning: Bitcoin Nerves, Dollar Surges, Amazon Go’s, Gas Prices Woes

September 27, 2018

Market Morning: Treasury Bear, Fed Fuss, Square FANGAS, And Dunkin’ Not...

September 26, 2018

Market Morning: EU Sidestepping Dollar, Navarro Defends Tariffs, Goldman Joins Instagram

September 25, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Parkinsons